Fig. 3From: Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart diseaseA Ferumoxytol-enhanced 4D flow measurements demonstrated less percent difference to 2D-PC flow measurements when compared to gadolinium-enhanced studies. B In subgroup analysis of low flows in 1V CHD, ferumoxytol-enhanced 4D Flow CMR measurements had stronger correlation to 2D-PCBack to article page